Filter
681
Filtered Results: 681
Text search:
endTB
Featured
Recommendations
75
New Publications
126
Language
Document type
No document type
312
Studies & Reports
139
Guidelines
94
Manuals
42
Strategic & Response Plan
39
Fact sheets
22
Training Material
11
Brochures
9
Situation Updates
7
Infographics
6
Countries / Regions
Germany
57
Global
29
Western and Central Europe
28
India
23
Eastern Europe
13
Kenya
12
South Africa
11
Latin America and the Carribbean
10
Asia
9
South–East Asia Region
9
Colombia
8
Senegal
8
Argentina
8
Brazil
8
Malawi
7
Africa
7
Ethiopia
7
Myanmar / Burma
7
Nepal
6
Sierra Leone
6
Syria
6
Bangladesh
6
Ukraine
5
Burkina Faso
5
Central African Republic
5
Liberia
5
Nigeria
4
Mozambique
4
Congo, Democratic Republic of
4
Ecuador
4
Timor Leste/ East Timor
3
El Salvador
3
Ghana
3
Niger
3
Peru
3
Uganda
3
Russia
3
Namibia
3
Zambia
3
Indonesia
3
Mexico
2
Estonia
2
Zimbabwe
2
Philippines
2
Venezuela
2
Jordan
2
West and Central Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Bolivia
2
Eswatini/ Swaziland
2
Pakistan
2
North Macedonia
1
Tajikistan
1
North Korea
1
Lesotho
1
Benin
1
Kazakhstan
1
Chile
1
Iran
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Tanzania
1
Paraguay
1
Uruguay
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Georgia
1
Honduras
1
Mali
1
Angola
1
Bhutan
1
South Sudan
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
187
Clinical Guidelines
49
Women & Child Health
23
Public Health
19
Key Resources
18
Pharmacy & Technologies
11
Capacity Building
6
Toolboxes
TB
296
Refugee
72
COVID-19
45
HIV
37
Mental Health
14
NTDs
13
Conflict
12
Caregiver
11
Health Financing Toolbox
11
Global Health Education
11
Planetary Health
10
Polio
9
AMR
9
Natural Hazards
7
NCDs
7
Ebola & Marburg
6
Rapid Response
4
Social Ethics
4
Malaria
4
Disability
3
Cholera
3
Pharmacy
3
NHSP 2017- 2022 (Final draft)
Исследование этого года основано на предыдущем отчете. В нем отслеживается утверждение последних стратегий, руководств и методов в пяти сферах: диагностика и иссл...
Indem sie die Deklaration „Universal health coverage: moving together to build a healthier world“ unterzeichnet hat, hat die Bundesregierung dieses Ziel im September 2019 noch einmal bekräftigt. Sie hat außerdem zugesichert, sich verstärkt um bisher besonders Benachteiligte zu kümmern und d...
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
Tuberculosis cases, TB deaths
BMC Infectious Diseases volume 23, Article number: 342 (2023).
Tuberculosis (TB) is among the leading causes of death globally. The disease has a huge burden in Namibia, with a case notification rate of at least 442 per 100,000. To date, Namibia is among the countries with the highest global TB bur...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
Issue Brief 8th edition.
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
La nueva hoja de ruta para poner fin a la TB en la población infantil y adolescente tiene un amplio público destinatario y alentamos a los países a que la adapten en función de su contexto nacional. Se prevé que utilicen la hoja de ruta los encargados de formular políticas a nivel nacional, re...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
